Profilo
Andrew B. Udell is Chief Commercial Officer at Actinogen Medical Ltd. since 2024.
Formerly, Mr. Udell was President-North America Region at Calliditas Therapeutics AB from 2021 to 2024 and Vice President-North America Commercial at NeuroDerm Ltd. from 2017 to 2018.
Mr. Udell completed undergraduate studies at Lehigh University and earned an MBA from the University of Connecticut.
Posizioni attive di Andrew Udell
| Società | Posizione | Inizio |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Corporate Officer/Principal | 15/10/2024 |
Precedenti posizioni note di Andrew Udell
| Società | Posizione | Fine |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 07/01/2024 |
| NEURODERM LTD | Corporate Officer/Principal | 01/06/2018 |
Formazione di Andrew Udell
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
NeuroDerm Ltd.
NeuroDerm Ltd. BiotechnologyHealth Technology Develops next-generation drug-device combination solutions for central nervous system disorders | Health Technology |
Actinogen Medical Ltd.
Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
















